Showing results (861-870 of 1,563) with videos related to
Sort By:
Pageof 157
Gynecologie, Obstetrique & Fertilite|July 23, 2008
[Oocyte and embryo quality: do the apoptotic markers have a place in the preimplantation genetic diagnostic?]D Haouzi, J De Vos, V Loup, et al.Leukemia|February 1, 1991
Hairy cell transformation of a B-cell chronic lymphocytic leukemia: a morphological, cytochemical, phenotypic and molecular studyE Duchayne, G Delsol, E Kuhlein, et al.Journal of the American Academy of Nurse Practitioners|March 11, 2004
Approaches to breast cancer screening among nurse practitionersSilvana Lawvere, Martin C Mahoney, Andrew B Symons, et al.The Journal of Pharmacology and Experimental Therapeutics|September 8, 2005
Modulation of cytochrome C oxidase-va is possibly involved in metallothionein protection from doxorubicin cardiotoxicityKevyn E Merten, Wenke Feng, Li Zhang, et al.Journal of Burn Care & Research : Official Publication of the American Burn Association|September 24, 2011
Predictive value of bronchoscopy in assessing the severity of inhalation injuryMichael J Mosier, Tam N Pham, David R Park, et al.Cytokine|April 1, 1997
Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptorJ Liautard, R X Sun, N Cotte, et al.International Journal of Cancer|July 15, 1977
Studies of bone and soft-tissue tumours induced in rats with radioactive cerium chlorideB Klein, S Pals, R Masse, et al.Journal of Neurochemistry|January 29, 2015
Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's diseaseJudy C Triplett, Zhaoshu Zhang, Rukhsana Sultana, et al.Breast Cancer Research and Treatment|June 29, 2002
Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancerA Buzdar, D Hayes, A El-Khoudary, et al.Cancer|January 15, 1980
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group BN I Nissen, T F Pajak, L A Leone, et al.Pageof 157